Northwestern Mutual Wealth Management
RGNX icon

Northwestern Mutual Wealth Management’s Regenxbio RGNX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,690
Closed -$27.8K – 3647
2023
Q3 		$27.8K Hold
1,690
– – ﹤0.01% 2199
2023
Q2 		$33.8K Hold
1,690
– – ﹤0.01% 2135
2023
Q1 		$32K Hold
1,690
– – ﹤0.01% 2104
2022
Q4 		$38.3K Buy
+1,690
New +$38.2K ﹤0.01% 2002

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Northwestern Mutual Wealth Management's RGNX Position: Q4 2023 in Review

Northwestern Mutual Wealth Management sold out of Regenxbio (RGNX) in Q4 2023, closing a stake of 1,690 shares — an estimated $27.8K sold.

Northwestern Mutual Wealth Management first reported a position in RGNX in Q4 2022 and held it in 4 quarters. The position peaked at $38.3K in Q4 2022. 171 funds tracked by Wall St. Rank hold RGNX as of Q4 2023.

  • Northwestern Mutual Wealth Management reported no remaining Regenxbio position as of Q4 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 1,690 Regenxbio shares in Q4 2023, an estimated $27.8K.
  • Northwestern Mutual Wealth Management first reported a position in Regenxbio in Q4 2022 and held it in 4 quarters.
  • Northwestern Mutual Wealth Management's Regenxbio position peaked at $38.3K in Q4 2022.
  • 171 funds tracked by Wall St. Rank held Regenxbio as of Q4 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2023, filed 13 Feb 2024.